secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001493152-25-011160
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharma receives Nasdaq bid price deficiency notice; 180 days to cure
------------------------------------------------------------------------

- Received Nasdaq letter on March 17, 2025 for failure to maintain minimum $1.00 bid price over 30 consecutive business days.
- Compliance period of 180 calendar days until September 15, 2025; must have $1.00 closing bid for 10 consecutive days.
- If not cured, may get additional 180 days by meeting other listing standards and providing intent to cure, e.g., reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/0001493152-25-011160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer